CEBPB emerges as a key regulatory factor in human cancers through diverse molecular mechanisms and clinical implications
Crossref DOI link: https://doi.org/10.1007/s12672-025-04122-6
Published Online: 2025-11-23
Update policy: https://doi.org/10.1007/springer_crossmark_policy
He, Anbang
Wu, Cunjin
Xia, Dan
Zhu, Yi
Text and Data Mining valid from 2025-11-23
Version of Record valid from 2025-12-29
Article History
Received: 2 July 2025
Accepted: 18 November 2025
First Online: 23 November 2025
Declarations
:
: Not applicable.
: The authors declare no competing interests.